3,5,3′,4′,5′ -Pentamethoxystilbene (MR-5), a synthetically methoxylated analogue of resveratrol, inhibits growth and induces G1 cell cycle arrest of human breast carcinoma MCF-7 Cells

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 1, 2010, Pages 226-234

  Pan, Min Hsiung ^a   Lin, Chih L I ^b   Tsal, Jie Heng ^c   Ho, Chi Tang ^d   Chen, Wei Jen ^c  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

3,5,3 ,4 ,5 pentamethoxystilbene (MR 5); CDK inhibitors (CKIS); Cell cycle; Cyclins; Cyclln dependent kinases (CDKS); G1 arrest; Resveratrol

Indexed keywords

EID: 75249101052     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf903067g     Document Type: Article

References (30)

1. (1) Burns, J.; Yokota, T.; Ashihara, H.; Lean, M. E.; Crozier, A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 2002, 50, 3337-3340. (Pubitemid 34533643)
2. (2) Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C; Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275 (5297), 218-220. (Pubitemid 127696281)
3. Chun, Y. J.; Kim, M. Y.; Guengerich, F. P. Resveratrol is a selective human cytochrome P450 IAl inhibitor. Biochem. Biophys. Res. Commun. 1999, 262(1), 20-24.
4. Ciolino, H. P.; Yeh, G. C. Inhibition of aryl hydrocarbon-induced cytochrome P-450 l A l enzyme activity and CYPlAl expression by resveratrol. Mol Pharmacol. 1999, 56 (4), 760-767.
5. (5) Szaefer, H.; Cichocki, M.; Brauze, D.; Baer-Dubowska, W. Altera-tion in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis, Nutr. Cancer 2004,48 (1), 70-77. (Pubitemid 38823548)
6. Fan, E.; Jiang, S.; Zhang, L.; Bai, Y, Molecular mechanism, of apoptosis induction by resveratrol, a natural cancer chemopreven-tive agent, Int. J. Vitam. Nutr. Res. 2008, 78 (1), 3-8.
7. Kundu, J. K.; Surh, Y. J. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269 (2), 243-261.
8. Carbo, N.; Costelli, P.; Baccino, F. M.; Lopez-Soriano, F. J.; Argiles, J. M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 1999, 254 (3), 739-743.
9. Athar, M.; Back, J. H.; Kopelovich, L.; Bickers, D. R.; Kim, A. L. Multiple molecular targets of resveratrol: anti-carcinogenic mecha-nisms, Arch. Biochem. Biophys. 2009, 486 (2), 95-102.
10. Malumbres, M.; Barbacid, M, Cell cycle, CDKs and cancer: a changing paradigm, Nat. Rev. Cancer 2009, 9 (3), 153-166.
11. Malumbres, M.; Barbacid, M. Mammalian cyclin-dependent kinases, Trends Biochem. Sci 2005, 30 (11), 630-641.
12. (12) Kaldis, P. The cdk-activating kinase (CAK): from, yeast to mammals. Cell. Mol. Life Sci 1999,55 (2), 284-296. (Pubitemid 29118894)
13. Sherr, C. J.; Roberts, J. M. CDK inhibitors: positive and negative regulators of Gl-phase progression. Genes Dev. 1999,13 (12), 1501-1512.
14. (14) Freemantle, S. J.; Liu, X.; Feng, Q.; Galimberti, F.; Blumen, S.; Sekula, D.; Kitareewan, S.; Dragnev, K. H.; Dmitrovsky, E. Cyclin degradation for cancer therapy and chemoprevention. J. Cell Bio-Chem. 2007,102 (4), 869-877. (Pubitemid 350036927)
15. (15) Yu, Q.; Geng, Y.; Sicinski, P. Specific protection against breast cancers by cyclin Dl ablation, Nature 2001, 411 (6841), 1017-1021. (Pubitemid 32612319)
16. Pan, M. H.; Gao, J. H.; Lai, C. S.; Wang, Y. J.; Chen, W. M.; Lo, C. Y.; Wang, M.; Dushenkov, S.; Ho, C. T. Antitumor activity of 3,5,4′- trimethoxystilbene in. COLO 205 cells and xenografts in. SCID mice. Mol- Carcinog. 2008, 47 (3), 184-196.
17. Lu, J.; Ho, C. H.; Ghai, G.; Chen, K. Y. Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Ba.x gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 2001, 22 (2), 321-328.
18. Agarwal, C; Dhanalakshmi, S.; Singh, R. P.; .Agarwal, R. Inositol hexaphosphate inhibits growth and induces Gl arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells, Neoplasia 2004, 6 (5), 646-659. (Pubitemid 39411101)
19. el-Deiry, W. S.; Harper, J. W.; ÓConnor, P. M,; Velculescu, V. E.; Canman, C. E.; Jackman, J.; Pietenpol, J. A.; Burrell, M,; Hill, D. E.; Wang, Y.; et al. WAFl/CIPl is induced in p53-mediated Gl arrest and apoptosis. Cancer Res. 1994, 54 (5), 1169-1174.
20. Parker, S. B.; Eichele, G.; Zhang, P.; Rawls, A.; Sands, A. T.; Bradley, A.; Olson, E. N.; Harper, J. W.; Elledge, S. J. p53-independent expression of p21Cipl in muscle and other terminally differentiating cells. Science 1995, 267 (5200), 1024-1027.
21. Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Roberti, M.; Pizzirani, D.; Meli, M.; Dusonchet, L.; Gebbia, N.; Abbadessa, V.; Crosta, L; Barucchello, R.; Grisolia, G.; Invidiata, F.; Simoni, D. Pterostilbene and 3́- hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells, Int J. Biochem. Cell Biol. 2005,37 (8), 1709-1726.
22. Simoni, D.; Roberti, M.; Invidiata, F. P.; Aiello, E.; Aiello, S.; Marchetti, P.; Baruchello, R.; Eleopra, M.; Di Cristina, A.; Grimaudo, S.; Gebbia, N.; Crosta, L.; Dieli, F.; Tolomeo, M. Stilbene-based anticancer agents: resveratrol analogues active to-ward HL60 leukemic cells with a non-specific phase mechanism. Bioorg. Med. Chem. Lett. 2006,16 (12), 3245-3248.
23. Ma, Z.; Molavi, O.; Haddadi, A.; Lai, R.; Gossage, R. A.; Lavasanifar, A. Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Cancer Chemother. Pharmacol. 2008, 63 (1), 27-35.
24. Wang, C; Li, Z.; Fu, M.; Bouras, T.; Pestell, R. G. Signal transduction mediated by cyclin Dl ; from mitogens to cell prolifera-tion: a molecular target with therapeutic potential. Cancer Treat. Res. 2004,119, 217-237.
25. (25) Kim, A. L.; Zhu, Y.; Zhu, H,; Han, L.; Kopelovich, L.; Bickers, D. R.; Athar, M. Resveratrol inhibits proliferation of human epider-moid carcinoma A431 cells by modulating MEKl and AP-I signal-ling pathways. Exp, Dermatol. 2006, 15 (1), 538-546. (Pubitemid 43834489)
26. (26) Gladden, A. B.; Diehl, J. A. Location, location, location: the role of cyclin Dl nuclear localization in cancer. J. Cell Biochem. 2005,96 (5), 906-913. (Pubitemid 41688717)
27. Kelly-Spratt, K. S.; Philipp-Staheli, J.; Gurley, K. E.; Hoon-Kim, K.; Knoblaugh, S.; Kemp, C. J. Inhibition of PI.-3.K restores nuclear p27(Kipl) expression in a mouse model of Kras-driven lung cancer. Oncogene 2009,28 (41), 3652-3662.
28. (28) McLean, G. W.; Carragher, N. O.; Avizienyte, E.; Evans, J.; Brunton, V. G.; Frame, M. C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity, Nat . Rev. Cancer 2005, 5 (7), 505-515. (Pubitemid 40942827)
29. Li, S.; Hua, Z. C. FAK expression regulation and therapeutic potential, Adv. Cancer Res. 2008, .101, 45-61.
30. Brunton, V. G.; Frame, M. C. Src and focal adhesion kinase as therapeutic targets in cancer. Curr. Opin. Pharmacol. 2008, 8 (4), 427-432.